Winters MA - Search Results

1

Detection and quantification of gene amplification products by a nonisotopic automated system.

Holodniy M, Winters MA, Merigan TC. Holodniy M, et al. Among authors: winters ma. Biotechniques. 1992 Jan;12(1):36, 38-9. Biotechniques. 1992. PMID: 1531177

2

Diurnal and short-term stability of HIV virus load as measured by gene amplification.

Holodniy M, Mole L, Winters M, Merigan TC. Holodniy M, et al. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):363-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7907661

3

Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.

Holodniy M, Katzenstein D, Winters M, Montoya J, Shafer R, Kozal M, Ragni M, Merigan TC. Holodniy M, et al. J Acquir Immune Defic Syndr (1988). 1993 Apr;6(4):366-9. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8095981

4

Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.

Winters MA, Holodniy M, Katzenstein DA, Merigan TC. Winters MA, et al. PCR Methods Appl. 1992 May;1(4):257-62. doi: 10.1101/gr.1.4.257. PCR Methods Appl. 1992. PMID: 1477661 Free article.

5

Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA.

Kroodsma KL, Kozal MJ, Hamed KA, Winters MA, Merigan TC. Kroodsma KL, et al. Among authors: winters ma. J Infect Dis. 1994 Nov;170(5):1292-5. doi: 10.1093/infdis/170.5.1292. J Infect Dis. 1994. PMID: 7963730

6

Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assays.

Shulman NS, Delgado J, Bosch RJ, Winters MA, Johnston E, Shafer RW, Katzenstein DA, Merigan TC. Shulman NS, et al. Among authors: winters ma. J Acquir Immune Defic Syndr. 2005 May 1;39(1):78-81. doi: 10.1097/01.qai.0000159517.78100.7b. J Acquir Immune Defic Syndr. 2005. PMID: 15851917

7

Quantitation of human immunodeficiency virus by culture and polymerase chain reaction in response to didanosine after long-term therapy with zidovudine.

Katzenstein DA, Winters M, Bubp J, Israelski D, Winger E, Merigan TC. Katzenstein DA, et al. J Infect Dis. 1994 Feb;169(2):416-9. doi: 10.1093/infdis/169.2.416. J Infect Dis. 1994. PMID: 7906292

8

Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons.

Lawrence J, Schapiro J, Winters M, Montoya J, Zolopa A, Pesano R, Efron B, Winslow D, Merigan TC. Lawrence J, et al. J Infect Dis. 1999 Jun;179(6):1356-64. doi: 10.1086/314751. J Infect Dis. 1999. PMID: 10228055 Clinical Trial.

9

HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.

Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Aguiniga E, Halpern J, Merigan TC. Kozal MJ, et al. Among authors: winters ma. J Acquir Immune Defic Syndr (1988). 1994 Aug;7(8):832-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7517448

10

Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.

Kozal MJ, Kroodsma K, Winters MA, Shafer RW, Efron B, Katzenstein DA, Merigan TC. Kozal MJ, et al. Among authors: winters ma. Ann Intern Med. 1994 Aug 15;121(4):263-8. doi: 10.7326/0003-4819-121-4-199408150-00005. Ann Intern Med. 1994. PMID: 7518658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters